Substantia nigra hyperechogenicity in Parkinson´s disease motor phenotypes
Objective: To evaluate substantia nigra hyperechogenicity (SN+) with transcranial sonography (TCS) in different PD motor subtypes. Background: Parkinson´s disease (PD) patients display a range of…Brain mechanisms underlying visual processing in Parkinson’s disease
Objective: We used fMRI and a visual cognitive task to study brain mechanisms underlying visual processing at different cognitive loads in patients with PD and…Evaluating quantitative EEG (QEEG) measures to differentiate between Parkinson’s disease (PD) patients and healthy individuals
Objective: To evaluate QEEG measures for classification of Parkinson's disease(PD) patients and healthy individuals, and eventually develop a pre-clinical composite biomarker to identify patients with…Does dopamine affect the selection of stepping actions in PD?
Objective: To compare the selection of stepping actions during a probabilistic reaction time task in the ON state with the OFF state in people with…The patient’s perspective: The effect of dopamine on Parkinson symptoms
Objective: To investigate the correlation between patient-based vs. clinician-based L-Dopa effects on PD symptoms in tremor-dominant patients. Background: Medication adjustments are often solely based on…Assessment of brainstem function with blink reflex variations in Parkinson’s disease
Objective: To assess the brainstem function with different variations of blink reflex studies in Parkinson's disease (PD). Background: Although PD presents principally as a movement…FYN expression is associated with regulatory region genetic variation
Objective: The hypothesis of this investigation was that FYN expression and promoter activity are significantly influenced according to genetic content. The objective of this investigation…Comparison of the utility of three cognitive scales for MDS Level-I diagnosis of mild cognitive impairment in Parkinson’s disease: MoCA, PD-CRS and ACE-III
Objective: To compare the utility for detecting Mild Cognitive Impairment in Parkinson's disease (PD-MCI) of three abbreviated global scales: the Montreal Cognitive Assessment (MoCA), the…Optic nerve integration as a visuospatial cognitive predictor in Parkinson’s disease
Objective: To explore the microstructural integrity of the optic nerve and its role as a cognitive predictor in patients with de novo Parkinson's disease (PD)…A proposed Parkinson’s disease neuropsychological battery (PNB)
Objective: To propose a neuropsychological battery for assessing cognitive abilities in Parkinson's disease (PD) that also fulfills proposed MDS diagnostic criteria for PD mild cognitive…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 207
- Next Page »